Yamasaki T, Kurokawa F, Shirahashi H, Kusano N, Hironaka K, Okita K
The First Department of Internal Medicine, Yamaguchi University, Ube, Yamaguchi, Japan.
Cancer. 2001 Apr 1;91(7):1342-8. doi: 10.1002/1097-0142(20010401)91:7<1342::aid-cncr1137>3.0.co;2-0.
Radiofrequency ablation (RFA) for patients with hepatocellular carcinoma (HCC) has been reported previously. This technique is superior to percutaneous microwave coagulation therapy (PMCT) for the enlargement of the necrotic area. Therefore, a few treatment sessions of RFA for patients with small HCC lesions measuring < 3 cm in greatest dimension can achieve complete necrosis. To achieve this with a one-treatment RFA session, the authors designed the technique of RFA with angiography combined with computed tomography (angio-CT) assistance. The advantages of this technique are that it is possible to detect small satellite nodules and to evaluate the real-time therapeutic effect immediately after RFA.
Ten patients with 12 HCC lesions measuring < 4 cm in greatest dimension underwent RFA with angio-CT assistance. The authors performed standard RFA for six patients (seven tumors) and RFA with balloon occlusion of the hepatic artery (balloon-occluded RFA [BoRFA]) for four patients (five tumors). Final therapeutic efficacy was evaluated with dynamic CT scans performed 2 weeks after treatment.
On CT arteriography (CTA) obtained immediately after treatment, a hyperattenuating ring around the nonenhanced region was apparent in all patients. On CT scans obtained 2 weeks after treatment, this ring disappeared, and the greatest dimension of the nonenhanced region was slightly larger than that on the CTA obtained immediately after treatment. The authors achieved complete eradication with one treatment session of RFA in 8 of 10 patients (80%). Local recurrence occurred in one patient 10 months after treatment. The greatest dimension of the area coagulated by BoRFA was significantly larger (greatest long-axis dimension, 38.2 +/- 2.8 mm; greatest short-axis dimension, 35.0 +/- 1.7 mm; n = 5 lesions) than without it (greatest long-axis dimension, 30.0 +/- 4.1 mm; greatest short-axis dimension, 27.0 +/- 4.3 mm; n = 4 lesions; greatest long-axis dimension, P = 0.009; greatest short-axis dimension, P = 0.006). No major complications occurred in any patient.
The authors were able to achieve success with a single treatment session in patients with small HCC using RFA with angio-CT assistance. They consider that RFA with angio-CT assistance is a safe and effective technique for the treatment of patients with small HCC.
先前已有关于肝细胞癌(HCC)患者射频消融(RFA)的报道。该技术在扩大坏死区域方面优于经皮微波凝固治疗(PMCT)。因此,对于最大直径<3 cm的小HCC病灶患者,进行几次RFA治疗即可实现完全坏死。为了通过一次RFA治疗达到这一目的,作者设计了血管造影联合计算机断层扫描(血管造影-CT)辅助下的RFA技术。该技术的优点是能够检测小的卫星结节,并在RFA后立即评估实时治疗效果。
10例有12个最大直径<4 cm的HCC病灶的患者接受了血管造影-CT辅助下的RFA治疗。作者对6例患者(7个肿瘤)进行了标准RFA,对4例患者(5个肿瘤)进行了肝动脉球囊闭塞下的RFA(球囊闭塞RFA [BoRFA])。治疗2周后通过动态CT扫描评估最终治疗效果。
治疗后立即进行的CT血管造影(CTA)显示,所有患者未强化区域周围均出现高密度环。治疗2周后的CT扫描显示,该环消失,未强化区域的最大直径略大于治疗后立即进行的CTA上的直径。10例患者中有8例(80%)通过一次RFA治疗实现了完全根除。1例患者在治疗10个月后出现局部复发。BoRFA凝固区域的最大直径(最大长轴直径,38.2±2.8 mm;最大短轴直径,35.0±1.7 mm;n = 5个病灶)明显大于未使用BoRFA时(最大长轴直径,30.0±4.1 mm;最大短轴直径,27.0±4.3 mm;n = 4个病灶;最大长轴直径,P = 0.009;最大短轴直径,P = 0.006)。所有患者均未发生严重并发症。
作者通过血管造影-CT辅助下的RFA能够在小HCC患者中单次治疗取得成功。他们认为血管造影-CT辅助下的RFA是治疗小HCC患者的一种安全有效的技术。